A detailed history of Carmichael Hill & Associates, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Carmichael Hill & Associates, Inc. holds 800 shares of JNJ stock, worth $131,856. This represents 0.05% of its overall portfolio holdings.

Number of Shares
800
Previous 800 -0.0%
Holding current value
$131,856
Previous $126,000 7.94%
% of portfolio
0.05%
Previous 0.05%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

SELL
$144.38 - $157.78 $45,912 - $50,174
-318 Reduced 1.48%
21,126 $3.09 Million
Q1 2024

Apr 24, 2024

SELL
$155.22 - $162.74 $55,879 - $58,586
-360 Reduced 1.65%
21,444 $3.39 Million
Q4 2023

Jan 23, 2024

SELL
$145.6 - $158.88 $81,099 - $88,496
-557 Reduced 2.49%
21,804 $3.42 Million
Q3 2023

Oct 30, 2023

SELL
$155.75 - $174.48 $23,362 - $26,172
-150 Reduced 0.67%
22,361 $3.48 Million
Q2 2023

Aug 04, 2023

BUY
$154.35 - $166.11 $6,482 - $6,976
42 Added 0.19%
22,511 $3.73 Million
Q1 2023

Apr 05, 2023

BUY
$151.05 - $180.26 $9,818 - $11,716
65 Added 0.29%
22,469 $3.48 Million
Q4 2022

Feb 13, 2023

SELL
$160.2 - $179.79 $92,435 - $103,738
-577 Reduced 2.51%
22,404 $3.96 Million
Q3 2022

Nov 10, 2022

SELL
$161.33 - $179.52 $40,332 - $44,880
-250 Reduced 1.08%
22,981 $3.75 Million
Q2 2022

Aug 05, 2022

SELL
$168.19 - $186.01 $74,003 - $81,844
-440 Reduced 1.86%
23,231 $4.12 Million
Q1 2022

May 16, 2022

BUY
$158.14 - $179.59 $22,455 - $25,501
142 Added 0.6%
23,671 $4.2 Million
Q4 2021

Jan 31, 2022

SELL
$155.93 - $173.01 $42,412 - $47,058
-272 Reduced 1.14%
23,529 $4.03 Million
Q3 2021

Nov 12, 2021

SELL
$161.5 - $179.47 $6,783 - $7,537
-42 Reduced 0.18%
23,801 $3.84 Million
Q2 2021

Aug 03, 2021

SELL
$159.48 - $171.07 $2,392 - $2,566
-15 Reduced 0.06%
23,843 $3.93 Million
Q1 2021

Apr 28, 2021

BUY
$153.07 - $170.48 $2,755 - $3,068
18 Added 0.08%
23,858 $3.92 Million
Q4 2020

Jan 27, 2021

BUY
$137.11 - $157.38 $4,935 - $5,665
36 Added 0.15%
23,840 $3.75 Million
Q3 2020

Nov 12, 2020

BUY
$140.38 - $153.83 $1,684 - $1,845
12 Added 0.05%
23,804 $3.54 Million
Q2 2020

Aug 05, 2020

SELL
$128.81 - $155.51 $87,590 - $105,746
-680 Reduced 2.78%
23,792 $3.35 Million
Q1 2020

May 05, 2020

SELL
$111.14 - $153.99 $38,787 - $53,742
-349 Reduced 1.41%
24,472 $3.21 Million
Q4 2019

Jan 30, 2020

SELL
$127.5 - $146.44 $13,387 - $15,376
-105 Reduced 0.42%
24,821 $3.62 Million
Q3 2019

Nov 06, 2019

SELL
$126.95 - $142.14 $13,456 - $15,066
-106 Reduced 0.42%
24,926 $3.23 Million
Q2 2019

Jul 30, 2019

SELL
$131.15 - $144.24 $32,394 - $35,627
-247 Reduced 0.98%
25,032 $3.49 Million
Q1 2019

Apr 23, 2019

SELL
$125.72 - $139.79 $132,760 - $147,618
-1,056 Reduced 4.01%
25,279 $3.53 Million
Q4 2018

Jan 16, 2019

SELL
$122.84 - $147.84 $128,244 - $154,344
-1,044 Reduced 3.81%
26,335 $3.4 Million
Q3 2018

Nov 09, 2018

BUY
$121.58 - $142.88 $1,458 - $1,714
12 Added 0.04%
27,379 $3.78 Million
Q2 2018

Aug 01, 2018

BUY
$119.4 - $131.76 $477 - $527
4 Added 0.01%
27,367 $3.32 Million
Q1 2018

Apr 27, 2018

SELL
$125.1 - $148.14 $57,295 - $67,848
-458 Reduced 1.65%
27,363 $3.51 Million
Q4 2017

Feb 07, 2018

BUY
$131.22 - $143.62 $3.65 Million - $4 Million
27,821
27,821 $3.89 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $431B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Carmichael Hill & Associates, Inc. Portfolio

Follow Carmichael Hill & Associates, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Carmichael Hill & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Carmichael Hill & Associates, Inc. with notifications on news.